Atlas Trials

A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668

Clinical trial NCT02313285 · COMPLETED

Trial details

NCT number
NCT02313285
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Study type
OBSERVATIONAL
Progressive Multiple Sclerosis
Start date
2015-01-12
Primary completion
2022-04-20
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.